Serial botulinum toxin a (BTX-A) injections for a fatal case of a neurogenic bladder caused by multiple sclerosis
Tomasz Drewa , Zbigniew WolskiCase Rep Clin Pract Rev 2007; 8:180-182 :: ID: 488674
Abstract
Background: Local administration of botulinum toxin A (BTX-A) inhibits presynaptic acetylcholine release. It is considered a novel option for the treatment of high pressure bladder.
Case Report: 26 old male suffering from multiple sclerosis, renal insufficiency and hiperkalimia caused by obstruction and small neurogenic bladder with urinary tract infection was presented. Live saving traetment included right percutaneus nephrostomy tube was performed. Patient refused bladder augmentation. He was treated with 3 procedures of botulinum toxin A injections (Dysport). Total dose was 1500 units. This treatment allowed to increase bladder capacity together with improvment of upper tract. Clean Intermitted Catheterization supported with α-blocker (8 mg daily) and oxibutinine (10 mg) daily allowed to prevent incontinence.
Conclusions: Botulinum toxin injections can serve as the first treatment of small spastic bladder even in cases where cystoplasty was usually considered.
Keywords: neurogenic bladder
787
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953173
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953192
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952818
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953608
Most Viewed Current Articles
07 Dec 2021 : Case report
22,364,578
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
174,245
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
119,744
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
64,648
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






